Australia Stock Exchange release from NOXOPHARM : First Patient Treated in CEP-2 Sarcoma Trial
27/02/2022 21:43
Australia Stock Exchange release from NOXOPHARM NOX.AX : First Patient Treated in CEP-2 Sarcoma Trial
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer